Home › Focal Segmental Glomerulosclerosis › Pennsylvania
Focal Segmental Glomerulosclerosis clinical trials in Pennsylvania
9 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Northeast Clinical Research Center, Bethlehem
- University of Pennsylvania, Philadelphia
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT07220083Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- St. Christopher's Hospital for Children, Philadelphia
Recruiting
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #19, Bridgeville
- Investigator Site #22, Butler
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07268638NEPTUNE Match Study
- Hospital of the University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Children's Hospital of Philadelphia, Philadelphia
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 17, 2026 · NCT05583942taVNS for FRNS in Children
- Children's Hospital of Philadelphia, Philadelphia
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 15, 2026 · NCT05588063A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- The Childrens Hospital of Philadelphia Kohls GI Nutrition and Diagnostic Center, Philadelphia
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Feb 3, 2026 · NCT05183646From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.